Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1515 studies found for:    "Chronic lymphocytic leukemia"
Show Display Options
Rank Status Study
1 Recruiting B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Condition: Chronic Lymphocytic Leukemia
Intervention:
2 Completed
Has Results
Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Ofatumumab;   Drug: Lenalidomide
3 Recruiting A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib
4 Active, not recruiting CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: Infusion of CD3/CD28 stimulated T cells
5 Active, not recruiting Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
Condition: Chronic Lymphocytic Leukemia
Intervention:
6 Completed Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: bendamustine hydrochloride;   Drug: mitoxantrone hydrochloride
7 Completed Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine plus Cyclophosphamide;   Drug: Fludarabine
8 Withdrawn HuMax-CD20 in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: HuMax-CD20
9 Completed Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Lenalidomida and Rituximab
10 Completed Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Other: Surface expression of functional biomarkers of the NK cell
11 Completed Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Procedure: Autologous stem cell transplantation;   Procedure: DHAP rescue and Autologous stem cell transplantation;   Procedure: DHAP rescue and F+C
12 Active, not recruiting Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention:
13 Terminated
Has Results
Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Maintenance lenalidomide
14 Completed A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Bendamustine, Rituximab, Lenalidomide
15 Recruiting Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab, Obinutuzumab, Idelalisib, or Ibrutinib in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: 20 mg/kg TRU-016 + Rituximab;   Biological: 10 mg/kg TRU-016 + Rituximab;   Biological: TRU-016 20 mg/kg + Obinutuzumab;   Biological: TRU-016 6-20 mg/kg + idelalisib + rituximab;   Biological: TRU-016 10-20 mg/kg + ibrutinib
16 Completed Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Other: bendamustine;   Other: rituximab
17 Completed Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Bendamustine;   Biological: Rituximab
18 Completed Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Bendamustine hydrochloride injection;   Drug: Chlorambucil
19 Active, not recruiting Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Ofatumumab
20 Completed Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Fludarabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.